Avidity Biosciences Stock Price Prediction
| RNA Stock | USD 47.12 0.40 0.86% |
Oversold Vs Overbought
45
Oversold | Overbought |
EPS Estimate Next Quarter (0.80) | EPS Estimate Current Year (2.86) | EPS Estimate Next Year (3.13) | Wall Street Target Price 68.55 | EPS Estimate Current Quarter (0.79) |
Using Avidity Biosciences hype-based prediction, you can estimate the value of Avidity Biosciences from the perspective of Avidity Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
Avidity Biosciences Hype to Price Pattern
Investor biases related to Avidity Biosciences' public news can be used to forecast risks associated with an investment in Avidity. The trend in average sentiment can be used to explain how an investor holding Avidity can time the market purely based on public headlines and social activities around Avidity Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Avidity Biosciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Avidity Biosciences.
The fear of missing out, i.e., FOMO, can cause potential investors in Avidity Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Avidity because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Avidity Biosciences after-hype prediction price | USD 46.33 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Avidity |
Avidity Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Avidity Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Avidity Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Avidity Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Avidity Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Avidity Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Avidity Biosciences' historical news coverage. Avidity Biosciences' after-hype downside and upside margins for the prediction period are 42.87 and 49.79, respectively. We have considered Avidity Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Avidity Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Avidity Biosciences is based on 3 months time horizon.
Avidity Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Avidity Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avidity Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Avidity Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 3.46 | 0.39 | 0.02 | 11 Events / Month | 14 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
47.12 | 46.33 | 0.83 |
|
Avidity Biosciences Hype Timeline
On the 11th of November 2024 Avidity Biosciences is traded for 47.12. The entity has historical hype elasticity of -0.39, and average elasticity to hype of competition of -0.02. Avidity is estimated to decline in value after the next headline, with the price expected to drop to 46.33. The average volatility of media hype impact on the company price is about 106.46%. The price depreciation on the next news is expected to be -0.83%, whereas the daily expected return is at this time at 0.12%. The volatility of related hype on Avidity Biosciences is about 2602.65%, with the expected price after the next announcement by competition of 47.10. About 98.0% of the company shares are owned by institutional investors. The book value of Avidity Biosciences was at this time reported as 12.19. The company recorded a loss per share of 2.95. Avidity Biosciences had not issued any dividends in recent years. Considering the 90-day investment horizon the next estimated press release will be in about 11 days. Check out Avidity Biosciences Basic Forecasting Models to cross-verify your projections.Avidity Biosciences Related Hype Analysis
Having access to credible news sources related to Avidity Biosciences' direct competition is more important than ever and may enhance your ability to predict Avidity Biosciences' future price movements. Getting to know how Avidity Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Avidity Biosciences may potentially react to the hype associated with one of its peers.
Avidity Biosciences Additional Predictive Modules
Most predictive techniques to examine Avidity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Avidity using various technical indicators. When you analyze Avidity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Avidity Biosciences Predictive Indicators
The successful prediction of Avidity Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Avidity Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Avidity Biosciences based on analysis of Avidity Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Avidity Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Avidity Biosciences's related companies. | 2023 | 2024 (projected) | Dividend Yield | 8.9E-5 | 7.9E-5 | Price To Sales Ratio | 69.12 | 65.66 |
Story Coverage note for Avidity Biosciences
The number of cover stories for Avidity Biosciences depends on current market conditions and Avidity Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Avidity Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Avidity Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Avidity Biosciences Short Properties
Avidity Biosciences' future price predictability will typically decrease when Avidity Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Avidity Biosciences often depends not only on the future outlook of the potential Avidity Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Avidity Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 73 M | |
| Cash And Short Term Investments | 595.4 M |
Complementary Tools for Avidity Stock analysis
When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |